Replaces Prod. #: ALX-270-209
Antitumor reagent. Topoisomerase II inhibitor. Induces apoptosis by FasL. Activates p53 resulting in upregulated expression of TRAIL-R2 (DR5) and Bak to overcome TRAIL resistance in Bax-deficient human colon carcinoma cancer cells.
Product Specification
Alternative Name: 4-Desmethylepipodophyllotoxin 9-(4,6-O-ethylidene)-β-D-glucopyranoside, VP-16-213
Formula: C29H32O13
MW: 588.6
Purity: ≥97% (HPLC)
Appearance: White to off-white powder.
CAS: 33419-42-0
MI: 14: 3886
RTECS: KC0190000
Source/Host: Semisynthetic derivative of podophyllotoxin.
Solubility: Soluble in DMSO, dimethyl formamide, ethyl ether or chloroform:methanol (1:1); slightly soluble in methanol or acetone; insoluble in water.
Shipping: AMBIENT
Long Term Storage: +20°C
Use/Stability: Store solutions in DMSO at 4°C. For long term storage prepare aliquots and store at -20°C. 
Hazard: MAY BE CARCINOGENIC.
TOXIC.
Handling: Protect from light and moisture.

Etoposide信息由上海叶舟生物科技有限公司为您提供，如您想了解更多关于Etoposide报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途